| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 35.07M | — |
| Operating expense | — | — |
| Net income | -22.39M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KPTI returned -68.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -73.4% |
| 1 year | -68.9% |
| 5 years | -97.7% |
| 10 years | -98.7% |
| All-time high | $698.25 (Jun 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KPTI would be worth today ›No. Karyopharm Therapeutics Inc. has not paid a dividend in the past 12 months.
Karyopharm Therapeutics Inc. stock trades on NASDAQ under the ticker symbol KPTI.
Karyopharm Therapeutics Inc. is part of the Healthcare sector.
Karyopharm Therapeutics Inc. has a market cap of 44.46M USD, based on the latest quote.
Karyopharm Therapeutics Inc. is scheduled to report earnings on Nov 3, 2026.
